FDA gives green signal to HealthPNX
Zebra Medical Vision- an Israel-based developer recently has received FDA’s approval to use Artificial Intelligence to scan and analyze chest X-rays. It will help identify pneumothorax which is the buildup of air inside the pleural cavity, caused by injury either to the lung or the chest wall. Usually, Pneumothorax is detected via chest X-rays, but it still remains difficult to diagnose. Called HealthPNX, it will benefit around 70,000 people affected in the U.S. by reducing the diagnostic time and accurate radiography results.
Advances in Cell Therapy for Diabetes
Semma Therapeutics- a Harvard-born startup has been success...
